Human monocytic myeloid‐derived suppressor cells impair B‐cell phenotype and function in vitro
Open Access
- 26 September 2019
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 50 (1) , 33-47
Abstract
Myeloid‐derived suppressor cells (MDSCs) are key regulators of immunity that initially have been defined by their ability to potently suppress T‐cell responses. Recent studies collectively demonstrate that the suppressive activity of MDSCs is not limited to T cells, but rather affects a broad range of immune cell subsets. However, relatively few studies have assessed the impact of MDSCs on B cells, particularly in the human context. Here, we report that human monocytic MDSCs (M‐MDSCs) significantly interfere with human B‐cell proliferation and function in vitro. We further show that the inhibition occurs independent of direct cell‐contact and involves the expression of suppressive mediators such as indoleamine 2, 3‐dioxygenase (IDO), arginase‐1 (Arg1), and nitric oxide (NO). In addition, our studies demonstrate that the suppression of B cells by M‐MDSCs is paralleled by a skewing in B‐cell phenotype and gene expression signatures. M‐MDSCs induced the downregulation of key surface markers on activated B cells, including IgM, HLA‐DR, CD80, CD86, TACI, and CD95. Concurrently, M‐MDSCs but not conventional monocytes elicited alterations in the transcription of genes involved in apoptosis induction, class‐switch regulation, and B‐cell differentiation and function. In summary, this study expands our understanding of the regulatory role of M‐MDSCs for human B‐cell responses.Keywords
Funding Information
- Ministerium für Wissenschaft, Forschung und Kunst Baden-Württemberg (SI‐BW 01222‐91)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Deutsche Forschungsgemeinschaft (CRC/SFB685, HA 5274/3‐1, INST 2388/33‐1)
This publication has 55 references indexed in Scilit:
- Metabolism of L-Arginine by Myeloid-Derived Suppressor Cells in Cancer: Mechanisms of T cell suppression and Therapeutic PerspectivesImmunological Investigations, 2012
- Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantationLeukemia, 2012
- Advances in Human B Cell Phenotypic ProfilingFrontiers in Immunology, 2012
- Increased Level of both CD4+FOXP3+ Regulatory T Cells and CD14+HLA-DR−/low Myeloid-Derived Suppressor Cells and Decreased Level of Dendritic Cells in Patients with Multiple MyelomaScandinavian Journal of Immunology, 2010
- Myeloid-derived suppressor cells as regulators of the immune systemNature Reviews Immunology, 2009
- Class Switch Recombination and Somatic Hypermutation in Early Mouse B Cells Are Mediated by B Cell and Toll-like ReceptorsImmunity, 2007
- l-arginine availability regulates T-lymphocyte cell-cycle progressionBlood, 2006
- Gr-1+CD115+ Immature Myeloid Suppressor Cells Mediate the Development of Tumor-Induced T Regulatory Cells and T-Cell Anergy in Tumor-Bearing HostCancer Research, 2006
- Regulation of immune responses by L-arginine metabolismNature Reviews Immunology, 2005
- Peroxynitrite reactivity with amino acids and proteinsAmino Acids, 2003